Leadless pacemaker and subcutaneous implantable cardioverter-defibrillator therapy: the first use of a novel treatment option in Poland

Kaczmarek, Krzysztof; Czarniak, Bartosz; Jakubowski, Piotr; Wranicz, Jerzy Krzysztof; Ptaszyński, Paweł

doi:10.5603/kp.2018.0126

Cited by 4 publications

(4 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…But when a patient was already equipped with a pacemaker, most of them tended to add an S-ICD if needed rather than to extract the pacing system to replace it with a T-ICD [16]. Nonetheless, the use of S-ICD in patients with pacemakers and paced rhythm is possible and has been reported for transvenous, epicardial and leadless pacemakers [17][18][19].…”

Section: Resultsmentioning

confidence: 99%

A survey study of the use of a subcutaneous implantable cardioverter-defibrillator in various clinical scenarios by expert electrophysiologists in Poland

et al. 2023

View full text Add to dashboard Cite

show abstract

Section: Resultsmentioning

confidence: 99%

A survey study of the use of a subcutaneous implantable cardioverter-defibrillator in various clinical scenarios by expert electrophysiologists in Poland

et al. 2023

View full text Add to dashboard Cite

show abstract

“…Reports are available of S-ICD systems co-existing with both transvenous and epicardial pacemakers [10][11][12][13]. Moreover, in isolated cases, the S-ICD system was used together with a leadless pacemaker [14][15][16]. On the other hand, several cases were reported where the implanted pacemaker changed QRS morphology to such an extent that continuation of S-ICD therapy was not possible [17].…”

Section: Discussionmentioning

confidence: 99%

Eligibility of patients with temporary paced rhythm for a subcutaneous implantable cardioverter-defibrillator

et al. 2022

View full text Add to dashboard Cite

Background: A concomitant use of a pacemaker and a subcutaneous implantable cardioverter-defibrillator (S-ICD) may be required in some patients.Aims: Our study aimed to evaluate the influence of permanent cardiac pacing on the morphology of the QRS complex in the context of S-ICD screening.Methods: One hundred patients with cardiac electronic implantable devices (CIEDs) were included in whom S-ICD screening could be performed both during intrinsic and paced rhythm. Results:The positive result of screening during spontaneous rhythm for at least one vector (in both supine and standing positions) was obtained in 80% and for 2 vectors in 59% of patients. Positive screening during paced rhythm for at least one vector was recorded in 36% of patients (78% right ventricular and 22% biventricular pacing) and for 2 vectors in 15% of patients (93% right ventricular and 7% biventricular pacing). At least one vector acceptable during both types of rhythm and in both positions was recorded in 23% of patients and at least 2 vectors in 8% of patients. Conclusions:The use of S-ICD in patients with paced ventricular rhythm is associated with a serious risk of inappropriate sensing due to different QRS morphology during intrinsic and paced rhythm, and it is particularly high in patients in whom periods of spontaneous rhythm interchange with periods of ventricular pacing. That risk has been hardly acknowledged in available reports, but according to our data, it is significant, and therefore it should be considered during S-ICD screening.

show abstract

“…For the same reason they started to be considered as a good solution for S-ICD patients in need for pacing (being the lesser evil inside the heart compared to traditional transvenous pacemakers). Since the first report of such a combined system [ 136 ], several patients were reported worldwide to have good outcomes of such a therapy [ 137 , 138 , 139 , 140 ].…”

Section: Coexistence With Transvenous Cardioverters-defibrillators An...mentioning

confidence: 99%

S-ICD Implantation "Tips and Tricks"

Budrejko¹,

Kempa²,

Przybylski³

2023

Rev. Cardiovasc. Med.

View full text Add to dashboard Cite

An implantable cardioverter-defibrillator (ICD) was developed to provide protection against sudden cardiac death. Despite being effective in terminating ventricular arrhythmias, traditional transvenous ICDs appeared over time to have certain limitations related to the need for vascular access and the presence of foreign material inside the circulatory system (namely lead failure and infections). A subcutaneous implantable cardioverter-defibrillator (S-ICD) was developed to overcome those limitations and to provide prevention against sudden cardiac death from outside the cardiovascular system. Utilization of that modern method of treatment is constantly increasing worldwide, and new centers incorporate implantation of that system in their portfolio. This review aims to present the most relevant issues related to S-ICD implantation procedure, based on experience of the authors and an extensive literature search.

show abstract

Leadless pacemaker and subcutaneous implantable cardioverter-defibrillator therapy: the first use of a novel treatment option in Poland

Cited by 4 publications

References 0 publications

A survey study of the use of a subcutaneous implantable cardioverter-defibrillator in various clinical scenarios by expert electrophysiologists in Poland

A survey study of the use of a subcutaneous implantable cardioverter-defibrillator in various clinical scenarios by expert electrophysiologists in Poland

Eligibility of patients with temporary paced rhythm for a subcutaneous implantable cardioverter-defibrillator

S-ICD Implantation "Tips and Tricks"

Contact Info

Product

Resources

About